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ECT, Sleep, and Biogenic Amines in 
Affective Illness 
To the Editors: 
With great interest, we read the study of 
Hoffmann et al. (1985) on the effects of 
electroconvulsive therapy (ECT) on sleep and 
biogenic amines. This study is a nice confirma- 
tion and generalization of the results of a case 
report we recently published (Grunhaus et al., 
1985). In that study we presented serial sleep 
recordings and dexamethasone suppression 
test (DST) results of a psychotically depressed 
patient undergoing ECT. Essentially, we 
found normalization of the latency of rapid 
eye movement (REM) sleep, decrease in REM 
density, and normalization of the DST with 
the treatment, similar to the results reported 
by Hoffmann et al. 
Several methodological questions are un- 
clear from the report of Hoffmann et al. They 
state that patients did not receive any anti- 
depressant treatment during the ECT course: 
did they receive any other form of psycho- 
tropic medication, e.g., benzodiazepines for 
sleep, or neuroleptics? A similar question 
arises with regard to the followup sleep 
recordings which occurred 9 to 1 I days after 
the ending of the ECT course; did they receive 
any psychotropic medication, such as starting 
a maintenance tricyclic antidepressant, during 
this interval between end of ECT and sleep 
recordings? The presence of psychotropic 
medications may significantly modify the 
sleep electroencephalogram (EEG) results and, 
thus, it is very important to clarify this point. 
An interesting point not addressed by the 
authors in their article is the stability of the 
sleep recordings across nights. We are current- 
ly analyzing the results of serial sleep EEG 
recordings in our own sample of patients 
treated with ECT. One of our interesting 
observations is that sleep recordings vary, on 
occasions greatly, from night to night. Some 
patients, following the full course of ECT 
treatment or advanced in the course, may 
show approximately normal REM latency 
one night and on the second night drop to 
20-30 minutes of REM latency. It is unclear to 
us the reason for such marked fluctuations. 
We do not have the advantage that Hoffmann 
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et al. apparently had (see above) of waiting 
9-14 days to institute the maintenance treat- 
ment after ECT; thus, it would be very 
interesting to note whether these changes in 
REM recording from one night to the other 
also occurred in their sample. The article 
reports means of 3 nights, but it would be of 
great interest if the authors could comment on 
the internight variability. 
The use of EEG recordings in the monitor- 
ing of ECT response is a novel and very 
interesting idea. In general, the use of sleep 
EEG as a device to monitor treatment has 
been limited by the impact that psychotropic 
medications have on its parameters. Its use 
during ECT avoids some of these limitations. 
In general, patients receiving ECT are more 
severely ill or have been resistant to medica- 
tions; an instrumental device which will help 
us monitor the course of treatment and 
possibly identify parameters associated with 
response or lack of response will most cer- 
tainly be welcomed and put to good use. Serial 
EEG sleep recording may well be one such 
device. 
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